Zacks Research Has Negative View of Revvity FY2025 Earnings

Revvity, Inc. (NYSE:RVTY - Free Report) - Equities researchers at Zacks Research reduced their FY2025 earnings per share estimates for shares of Revvity in a research note issued on Monday, April 14th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $4.94 per share for the year, down from their previous forecast of $4.95. The consensus estimate for Revvity's current full-year earnings is $4.94 per share. Zacks Research also issued estimates for Revvity's Q1 2026 earnings at $1.10 EPS, Q2 2026 earnings at $1.34 EPS, FY2026 earnings at $5.45 EPS, Q1 2027 earnings at $1.29 EPS and FY2027 earnings at $6.18 EPS.

A number of other analysts have also recently weighed in on the company. Barclays reduced their price target on Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Raymond James reiterated an "outperform" rating and set a $145.00 price target (up previously from $140.00) on shares of Revvity in a report on Monday, February 3rd. Wells Fargo & Company decreased their price objective on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a report on Thursday. KeyCorp upped their price target on shares of Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. Finally, Sanford C. Bernstein lowered Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price objective on the stock. in a research note on Friday, January 10th. Four research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $131.42.

Revvity Stock Down 2.1 %

NYSE:RVTY traded down $1.93 during mid-day trading on Wednesday, reaching $91.82. The stock had a trading volume of 1,352,557 shares, compared to its average volume of 891,845. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. Revvity has a fifty-two week low of $89.61 and a fifty-two week high of $129.50. The business's 50 day moving average is $106.77 and its 200 day moving average is $114.14. The stock has a market cap of $11.03 billion, a P/E ratio of 41.55, a PEG ratio of 3.82 and a beta of 1.07.

Revvity (NYSE:RVTY - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. During the same quarter last year, the business earned $1.25 earnings per share.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be given a $0.07 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $0.28 annualized dividend and a yield of 0.30%. Revvity's dividend payout ratio (DPR) is currently 12.67%.

Insiders Place Their Bets

In other news, insider Joel S. Goldberg sold 15,170 shares of the company's stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the sale, the insider now directly owns 33,400 shares in the company, valued at approximately $4,232,782. This represents a 31.23 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.68% of the company's stock.

Institutional Trading of Revvity

Several institutional investors have recently bought and sold shares of RVTY. Assetmark Inc. boosted its stake in shares of Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after purchasing an additional 259 shares in the last quarter. Optiver Holding B.V. bought a new stake in Revvity during the fourth quarter worth about $33,000. Quarry LP raised its stake in shares of Revvity by 45.7% in the fourth quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after acquiring an additional 95 shares during the last quarter. Millstone Evans Group LLC acquired a new position in shares of Revvity in the 4th quarter worth approximately $38,000. Finally, Vermillion Wealth Management Inc. bought a new stake in Revvity during the 4th quarter worth approximately $41,000. Institutional investors and hedge funds own 86.65% of the company's stock.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.